Immunohistochemical characterization of glomerular PDGF B-chain and PDGF β-receptor expression in diabetic rats

Diabetes Research and Clinical Practice

Volumn 48, Issue 2, 2000, Pages 87-98

  Nakagawa, Hiroko ^a   Sasahara, Masakiyo ^a   Haneda, Masakazu ^a   Koya, Daisuke ^a   Hazama, Fumitada ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Diabetic nephropathy; Immunohistochemistry; Mesangial cells; Platelet derived growth factor; Visceral epithelial cells

Indexed keywords

INSULIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRAPIDIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EPITHELIUM CELL; GLOMERULOSCLEROSIS; GLOMERULUS; IMMUNOHISTOCHEMISTRY; MALE; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; IMMUNOHISTOCHEMISTRY; INSULIN; KIDNEY GLOMERULUS; MALE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TIME FACTORS;

EID: 0034107826     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00144-8     Document Type: Article

References (40)

1. Floege J., Eng E., Young B.A. et al. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation on rats. J. Clin. Invest. 92:1993;2952-2962.
2. Isaka Y., Fujiwara Y., Ueda N., Kaneda Y., Kamada T., Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 92:1993;2597-2601.
3. Ross R. Platelet-derived growth factor. Lancet. 8648:1989;1179-1182.
4. Iida H., Seifert R., Alpers C.E. et al. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc. Natl. Acad. Sci. USA. 88:1991;6560-6564.
5. Johnson R.J., Raines E.W., Floege J. et al. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J. Exp. Med. 175:1992;1413-1416.
6. Yoshimura A., Gordon K., Alpers S.E. et al. Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int. 40:1991;470-476.
7. Futamura A., Izumino K., Nakagawa Y., Takata M., Inoue H., Iida H. Effect of the platelet-derived growth factor antagonist trapidil on mesangial cell proliferation in rats. Nephron. 81:1999;428-433.
8. Mauer S.M. Structural-functional correlations of diabetic nephropathy. Kidney Int. 45:1994;612-622.
9. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Kidney size and glomerular volume. Diabetologia. 16:1979;125-128.
10. Sayed-Ahmed N., Muchaneta-Kubara E.C., Besbas N., Shortland J., Cope G.H., el Nahas A.M. Insulin-like growth factor-I and experimental diabetic kidney disease. Exp. Nephrol. 1:1993;364-371.
11. Sharma K., Ziyadeh F.N. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. Am. J. Physiol. 267:1994;F1094-F1101.
12. Di Paolo S., Gesualdo L., Ranieri E., Grandaliano G., Schena F.P. High glucose concentration induces the overexpression of transforming growth factor-β through the activation of a platelet-derived growth factor loop in human mesangial cells. Am. J. Pathol. 149:1996;2095-2106.
13. Inaba T., Ishibashi S., Gotoda T. et al. Enhanced expression of platelet-derived growth factor-β receptor by high glucose. Involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes. 45:1996;507-512.
14. Nakamura T., Fukui M., Ebihara I. et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 42:1993;450-456.
15. Shiraishi T., Morimoto S., Itoh K. et al. Radioimmunoassay of human platelet-derived growth factor using monoclonal antibody toward a synthetic 73-97 fragment of its B-chain. Clin. Chim. Acta. 184:1989;65-74.
16. Ross R., Masuda J., Raines E.W. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science. 248:1990;1009-1012.
17. Floege J., Burns M.W., Alpers C.E. et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int. 41:1992;297-309.
18. Itagaki I., Shimizu K., Kamanaka Y. et al. The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats. Diabetes Res. Clin. Pract. 25:1994;147-154.
19. Weibel E.R. Stereological Methods: Practical Methods for Biological Morphometry. 1979;51-57 Academic Press, London.
20. McKay J.S., Blakemore W.F., Franklin R.J. The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS. Neuropathol. Appl. Neurobiol. 23:1997;50-58.
21. Alpers C.E., Seifert R.A., Hudkins K.L., Johnson R.J., Bowen-Pope D.F. PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int. 43:1993;286-294.
22. Floege J., Johnson R.J., Alpers C.E. et al. Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am. J. Pathol. 142:1993;637-650.
23. Gesualdo L., Di Paolo S., Milani S. et al. Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. J. Clin. Invest. 94:1994;50-58.
24. Gesualdo L., Di Paolo S., Ranieri E., Schena F.P. Trapidil inhibits human mesangial cell proliferation: effect on PDGF beta-receptor binding and expression. Kidney Int. 46:1994;1002-1009.
25. Sharma K., Jin Y., Guo J., Ziyadeh F.N. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes. 45:1996;522-530.
26. Throckmorton D.C., Brogden A.P., Min B., Rasmussen H., Kashgarian M. PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int. 48:1995;111-117.
27. Schultz P.J., Di Corleto P.E., Silver B.J., Abboud H.E. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am. J. Physiol. 255:1988;F674-F684.
28. Doi T., Vlassara H., Kirstein M., Yamada Y., Striker G.E., Striker L.J. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 89:1992;2873-2877.
29. Zhou X., Hurst R.D., Templeton D., Whiteside C.I. High glucose alters actin assembly in glomerular mesangial and epithelial cells. Lab. Invest. 73:1995;372-383.
30. van Det N.F., van den Born J., Tamsma J.T. et al. Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. Kidney Int. 49:1996;1079-1089.
31. Kerjaschki D. Dysfunctions of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases. Kidney Int. 45:1994;300-313.
32. Salant D.J. The structural biology of glomerular epithelial cells in proteinuric diseases. Curr. Opin. Nephrol. Hypertens. 3:1994;569-574.
33. Abboud H.E. Resident glomerular cells in glomerular injury: mesangial cells. Semin. Nephrol. 11:1991;304-311.
34. Kikkawa R., Umemura K., Haneda M., Arimura T., Ebata K., Shigeta Y. Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes. 36:1987;240-243.
35. Haneda M., Araki S., Togawa M., Sugimoto T., Isono M., Kikkawa R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes. 46:1997;847-853.
36. Koya D., Jirousek M.R., Lin Y.W., Ishii H., Kuboki K., King G.L. Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J. Clin. Invest. 100:1997;115-126.
37. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl. J. Med. 318:1988;1315-1321.
38. Makita Z., Radoff S., Rayfield E.J. et al. Advanced glycosylation end products in patients with diabetic nephropathy. New. Engl. J. Med. 325:1991;836-842.
39. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes. 47:1998;859-866.
40. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.